u-5 gliadin
Introduction
Wheat-dependent exercise-induced anaphylaxis (WDEIA) is a distinct form of wheat allergy typically induced by exercise after the ingestion of wheat products. 1 The estimated prevalence of wheat allergy in European residents is 0.1e3.9% in a meta-analysis, and, is 0.21% in Japanese adults in a cross-sectional study in rural mountainous area in Japan. 2, 3 There is no established treatment for WDEIA, and therefore, patients have no choice but to limit their intake of wheat products. Because wheat is one of the staple foods in the human diet, this limitation significantly lowers the quality of life of WDEIA patients. The risk of elicitation of allergic symptoms can be reduced by the limitation of exercise after ingestion of wheat, although this is not always reliable.
Prior to the induction of allergic symptoms, sensitization of wheat allergens is established in some way. Although the mechanism has not been fully clarified, the intestinal transmission capability of wheat allergens 4 and increased serum allergen level following exercise and/or aspirin intake are considered to elicit symptoms in patients with WDEIA. 5e7 Thus, lowering of the oral sensitization ability of wheat products may facilitate an effective prevention measure against the onset of WDEIA.
Wheat u-5 gliadin is one of the major allergens in WDEIA 1,8e12 ; therefore, wheat cultivars with reduced u-5 gliadin content can be considered hypoallergenic wheat. Denery-Papini et al. 13 and Lauri ere et al. 14 evaluated the u-gliadin content in wheat cultivars widely consumed in Europe. Altenbach et al. 15 reported a genetically modified wheat in which the u-5 gliadin genes were silenced by a siRNA technique. However, those studies were scant in practical in vivo research. Furthermore, while gluten-free bread has been made with glutathione-added rice flour, 16 such bread completely lacks the characteristic flavour and taste of bread made with regular wheat flour. In the present study, we selected a hypoallergenic wheat line that lacks the u-5 gliadin protein and evaluated its sensitization ability by using a possible animal model of wheat allergy.
Methods

Selection of wheat strains
The u-5 gliadin gene is located on the short arm of chromosome 1B in wheat. 17 Therefore, we searched for candidate wheat lines among the deletion stocks of common wheat on the website of the National Bioresource Project (NBRP)-WHEAT (www.nbrp.jp/ reportProject.jsp?project¼wheat) and obtained candidate deletion lines and other lines from NRBP-Wheat (Table 1) . These lines were established in a cultivar of common wheat (Triticum aestivum L. 2n ¼ 6x ¼ 42; genome formula, AABBDD), namely Chinese Spring. First, to reconfirm the chromosomal location of the gene encoding u-5 gliadin, we analysed the group-1 nullisomicetetrasomic series of Chinese Spring wheat. These lines lack a pair of chromosomes (e.g. 1A) and carry 4 doses of either of the homoeologous chromosomes (e.g. 1B or 1D) to compensate the loss of the critical chromosome. Then, we evaluated the in vitro allergenicity of the flour from chromosome 1B deletion stocks having partial deficiencies in the long arm, short arm, and satellite of the chromosome.
Production of polyclonal IgG against u-5 gliadin epitope peptides
We synthesized the peptide KQQSPEQQQFPQQQIPQQQ, including 3 IgE-binding epitope sequences of u-5 glia-dindQQIPQQQ, QQFPQQQ, and QQSPEQQdand conjugated it with keyhole limpet haemocyanin (KLH). 11 We injected the KLHconjugated peptide mixed with adjuvant subcutaneously into a New Zealand white rabbit 3 times at 2-week intervals. We confirmed the production of the IgG antibodies against the u-5 gliadin-epitope peptide by enzyme-linked immunosorbent assay and then purified the IgG antibodies (anti-u-5 gliadin) using a peptide affinity column. We confirmed the binding of u-5 gliadin to each of the epitope sequences with synthetic peptide arrays (data not shown). In addition to the specific binding with u-5 gliadin, we observed several non-specific bands (see Fig. 1a , bottom, lane CS).
Extraction of gliadins
We mashed 4 grains (56e160 mg) of each of the wheat lines into flour using TissueLyser (Qiagen, Venlo, Netherlands) for 30e40 min. Then, we added 1 mL of 50% 1-propanol (Wako Pure Chemical Industries, Osaka, Japan) to the flour and stirred the mixture for 20 min at room temperature. After centrifuging the mixture for 20 min (7000 Âg) at room temperature, we dried the supernatant containing gliadins by vacuum drying and stored the dried material at À20 C until analysis.
Sodium dodecyl sulphateepolyacrylamide electrophoresis and western blotting
We dissolved the wheat proteins into a sodium dodecyl sulphateepolyacrylamide electrophoresis (SDS-PAGE) sample buffer (2% SDS, 10% glycerol, 5% 2-mercaptoethanol, 0.002% bromophenol blue, 62.5 mM TriseHCl; pH 6.8) and conducted SDS-PAGE in 12.5% acrylamide gels. We stained separated proteins with Coomassie brilliant blue (CBB) to visualize them. For immunoblotting, we electrophoretically transferred the separated proteins to a polyvinylidene difluoride membrane (Immobilon-P; Millipore, Billerica, MA, USA) and blocked the membrane with 5% skim milk in TBST (50 mM Trisebuffered saline, 1% Tween 20; pH 7.4). We washed the membrane thrice with TBST and then probed it with anti-u-5 gliadin IgG. Next, we incubated the membrane with horseradish peroxidase (HRP)-conjugated goat anti-rabbit IgG (BioSource International, Camarillo, CA, USA). To visualize the protein bands, we used ECL Plus Western Blotting Detection Reagents (GE Healthcare, Little Chalfont, UK) and autoradiography films.
Reverse phase-high performance liquid chromatography
We dissolved the extracted gliadins in distilled water containing 0.1% trifluoroacetic acid (TFA) (v/v) and analysed the gliadin solution (3.3 mg/mL, 30 mL) with a HPLC system (model Prominence, Shimadzu, Kyoto, Japan) equipped with a Jupiter 5u C18 300A column (4.6 Â 250 mm; Phenomenex, Torrance, CA, USA). The gradient of the elution solvents A [0.1% TFA (v/v)] and B [99.9% acetonitrile, 0.1% TFA (v/v)] was linear from 10% to 80% B.
Propagation and flour milling of the hypoallergenic wheat line
We cultivated the 1BS-18 line at the experimental farm of the Graduate School of Agriculture, Kyoto University, to increase the seed. Using the increased seed, we produced 263 kg of grains from 2-year cultivation in a field at the Mountainous Region Research Center of Shimane prefecture. The grains were carefully milled into flour by a flour milling company (Satake, Hiroshima, Japan), and care was taken to avoid contamination. We confirmed by western blotting that the flour from the 1BS-18 strain had no u-5 gliadin contamination.
Evaluation of sensitization ability of the 1BS-18 gluten in a guinea pig wheat challenge model
We obtained an average of 37.7 g gluten from 100 g of the 1BS-18 flour by kneading the flour with water to remove water-soluble proteins; we repeated this process to accumulate sufficient gluten for subsequent experiments. We used commercially available regular gluten (Ezaki Glico, Osaka, Japan) as a control. To prepare application solutions of 1BS-18 gluten and control gluten, we added 1400 mL of 1% of acetic acid to 200 g of gluten and mixed it for 16 h at room temperature. We collected the supernatant into a new tube after centrifugation (20,000 Âg for 15 min at 4 C) and emulsified the gluten solution (80 mg/mL) by adding an equal volume of coconut oilelecithin (4:1) mixture.
All animal experiments were performed at LSI Medience Corporation (LSI Medience Corporation, Kumamoto, Japan). To evaluate the sensitization ability of 1BS-18 gluten, a guinea pig wheat challenge model was employed according to a mouse model of food allergy reported previously. 18, 19 According to the application and challenge protocol shown in Figure 2 and 20 6-week-old male Kud:Hartley guinea pigs purchased from Kudo (Saga, Japan) were randomly divided into 2 groups: control gluten (n ¼ 10) and 1BS-18 gluten (n ¼ 10). The guinea pigs were fasted for 16 h prior to application. On day 1, 7% sodium hydrogen carbonate (20 mL/kg) and salicylic acid (10 mg/mL in 0.5% methylcellulose, 20 mL/kg) were administered through per-oral gastric tube to neutralize gastric acid, and 1 h later the gluten solution (40 mg/mL, 20 mL/kg) was injected into stomach through the gastric tube. From day 2e10, the application process was repeated every day. The application was continued until day 14 and a gluten/exercise challenge test was performed on day 15. If half of the animals showed allergy scores (calculated as below) more than 1, the application was stopped and the gluten/exercise challenge test was done at the next day. For the gluten/exercise challenge test, sodium hydrogen carbonate, salicylic acid, and gluten solution was administered, then the animals were loaded with exercise using a treadmill for 30 min at condition of 15 m/min, 20% gradients. Allergy scores were calculated by the summation of the following index, which was a slight modification of previously described by Cueto-Sola et al. 20 : 0 ¼ no symptoms 1 ¼ pilar erecti, scratching and rubbing around the nose and head; 2 ¼ redness and puffiness reaction, diarrhoea; 3 ¼ wheezing, laboured respiration, and cyanosis around the mouth and tail; 4 ¼ death. For instance, if a guinea pig had symptoms of scratching around the nose and head (1), redness and puffiness reaction and diarrhoea (2) and wheezing, laboured respiration, and cyanosis (3), the allergic score is 1 þ 2 þ 3 ¼ 6. After this, the same gluten solution (20 mL/kg) was additionally administered by intraperitoneal (IP) injection, and 30 min later, the allergy scores were recorded in the same way.
Statistical analysis
We performed two-sided t-tests using SPSS ver. 20 (IBM, Armonk, NY, USA) to analyse the allergy scores in the animal experiment P-values less than 0.05 were considered statistically significant.
Ethics
We performed all the animal experiments with the approval of the ethics committee for animal studies of LSI Medience Corporation (Tokyo, Japan).
Results
Screening for u-5 gliadin-deficient lines
We detected u-5 gliadin by SDS-PAGE (Fig. 1a, top) and western blotting (Fig. 1a, bottom) in NT1A1B, NT1A1D, NT1D1A, and NT1D1B but not in NT1B1A or N1B1D. This result indicated that Fig. 2 . Scheme of the application and challenge tests using gluten from 1BS-18 and control flour. (a) Gluten application schedule for guinea pigs: 1BS-18 group, from day 0e14; control group, from day 0e13 (see the text for the detailed steps). During the application, 2 and 5 of animals were removed from the 1BS-18 group and the control group, respectively. (b) Protocol for the gluten and exercise challenge test and intraperitoneal (IP) administration (see the text for the detailed steps). the gene encoding u-5 gliadin is present on chromosome 1B.
Then, we investigated 1 deletion line for the 1BL arm and 7 deletion stocks for the 1BS arm and satellite. We found that all the deletion stocks for the satellite except 1BS-04 lacked the u-5 gliadin protein (Fig. 1a) , and we confirmed the same result by reverse phase-high performance liquid chromatography (RP-HPLC) (Fig. 1b) . Since the 1BS-18 line has the smallest deletion of the 1BS satellite (Table 1) , we employed this line as a representative hypoallergenic wheat line for the gluten allergenicity test described below.
Comparison of gluten allergenicity between the regular and 1BS-18 wheat flour in the guinea pig wheat challenge model
The control guinea pig group was fed with regular gluten and 5 of the 10 animals were withdrawn during the application period because of unhealthy condition (Fig. 2) . The autopsy of the sacrificed guinea pigs showed bleeding in the duodenum, suggesting the mucosal damage in the gastrointestinal tract. In the control gluten group, more than half of animals in this group showed allergy score more than 1 on day 13, then we performed gluten/exercise challenge test with the 5 surviving guinea pigs on day 14 by forcing them to exercise after oral administration of the regular gluten. All of them had allergy scores 1 to 3, suggesting that the animals had been sensitized with the regular gluten ( Table 2) . The sensitization was further tested by IP injection of the gluten, and higher allergy scores were seen (4 to 6). Although the effect of exercise in the challenge test was not observed, these results suggest that these guinea pigs were sensitized with the regular gluten.
The same experiment was performed with 1BS-18 gluten. During the application period, 2 of the 10 tested guinea pigs were withdrawn because of the similar unhealthy condition as seen in the regular gluten group. Challenge test was performed with the remaining 8 guinea pigs on day 15, forcing them to exercise after oral administration of 1BS-18 gluten. As summarized in Table 2 , the average allergy score of the 1BS-18 group was 0.0 in the case of oral gluten administration and 0.4 in the case of IP gluten injection; these scores were significantly lower than those of the control group: 1.4 in the case of oral gluten administration and 4.4 in the case of IP gluten injection.
Discussion
In the present study, we demonstrated by the protein analysis that most of the wheat deletion lines with deficiencies in the satellite of chromosome 1B lacked genes encoding u-5 gliadin. Based on the observation, we selected a deletion line, 1BS-18, as the best candidate for the breeding of hypoallergenic wheat, because it has the smallest deletion involving the u-5 gliadin gene locus. The smaller deletion of chromosome 1B is desirable for the growth and harvest of wheat.
We evaluated the hypoallergenic nature of this line by in vivo experiments using the guinea pig wheat challenge model, and found that 1BS-18 gluten-induced allergic scores were milder than those induced with regular gluten, suggesting a low allergenicity of 1BS-18 compared with regular wheat. During the application process of gluten with sodium hydrogen carbonate and salicylic acid, 5 animals in the control group and 2 animals the 1BS-18 group were removed because of unhealthy conditions (Fig. 2) . It is unlikely that the condition seen in the application period is due to allergic reaction because sensitization needs fundamentally a couple of weeks. In a preliminary experiment, we found that enough amount of gluten (800 mg/kg body weight) is necessary to induce allergic symptoms for guinea pigs in the presence of sodium hydrogen carbonate and salicylic acid. In addition, absorption of allergens is known to increase after the administration of aspirin, which is metabolically converted to salicylic acid. 1, 21 Therefore, we used salicylic acid for gluten challenging. But the administration of salicylic acid in this study may have caused the gastrointestinal damage in combination to relatively large amount of gluten application. The hyposensitization ability of 1BS-18 gluten is supported by the fact that low allergy scores were seen in the 1BS-18 group compared to those in the control group in the challenge tests as well as IP administration. As in humans, u-5 gliadin sensitization is probably implicated in the development of wheat allergy in guinea pigs. The fact that we have failed to measure the antigen-specific IgE of guinea pigs was a limitation of our study.
Several studies on hypoallergenic wheat have been reported. Kumagai et al. 22 revealed that deamination by hydrolysis with an ion-exchange regime is useful to reduce the allergenicity of wheat protein and that the deaminated wheat proteins induce oral immunological tolerance in rats allergic to wheat. 23 However, deamination is far from practical use because of the difficulty of its application on a large scale. The enzymatic fragmentation of proteins in wheat flour by proteases also reduces wheat allergenicity. 24 However, the use of such flour for wheat products such as bread and noodles is difficult owing to the state losing specific viscous elasticity of gluten and altered processing characteristics of wheat gluten after the enzymatic degradation.
1BS-18 flour differed from regular flour only in the lack of u-5 gliadin, i.e. it had not been subjected to any chemical or enzymatic treatments. In addition, the 1BS-18 line does not meet the definition of genetically modified crops because there is no insertion of foreign genes. 17 Thus, the 1BS-18 line can be an excellent parent for the development of commercial hypoallergenic wheat cultivars. Although the 1BS-18 line is an aneuploid of a low-yielding cultivar, Chinese Spring, commercial hypoallergenic wheat can be crossbred for better yield and quality by repeated backcrossing of the 1BS-18 line to elite commercial cultivars.
We selected a deletion line of Chinese Spring 1BS-18 as a representative hypoallergenic wheat line lacking u-5 gliadin. We demonstrated the hyposensitization ability of 1BS-18 gluten in a guinea pig wheat challenge model, suggesting that the use of the flour of such hypoallergenic wheat lacking u-5 gliadin possibly be a prophylactic approach for wheat allergy including WDEIA. 0 (day 14) 0 0 10 0 (day 14) 0 0 Mean ± SD 0 ± 0.0 0 ± 0.0 0.4 ± 0.5
The allergic scores in application and both challenge tests were significantly lower (P < 0.05) in the 1BS-18 group than in the control group.
